Newsroom | Boston Children's Hospital

Top Storylines and Resources

Camp Zon Research Internship Application

February 19, 2021 Our Camp Zon Internship Application is now open to high school students for a virtual research experience that will take place July 19-30, 2021! Deadline to apply is April 1, 2021. Please read more about this opportunity and apply here: Learn more about Camp Zon here:... Read More »

Barry Paw Lectureship with David M. Langenau, PhD

January 11, 2021 David M. Langenau, PhD is awarded second recipient of the Barry Paw Lectureship. Join us this Thursday, January 14th at 4pm for the Barry Paw Lectureship with Dr. David M. Langenau hosted by the Dept. of Pediatrics Hematology/ Oncology Series! Please click this link to join the webinar: Passcode: 4pmseminar... Read More »

Kim Lab’s Work on Earlier Detection of Lung Cancer Selected as Top 5 Damon Runyon Scientific Discoveries of 2020

January 5, 2021 “Lung cancer is often missed in its earlier stages and, as a result, is the leading cause of cancer deaths in the United States. To tackle this issue, Damon Runyon Fellow Aaron L. Moye, PhD, and colleagues at Harvard Medical School and Boston Children’s Hospital have developed a platform to study early-stage […]... Read More »

Aaron L. Moye, PhD named Rising Star on list of 1000 Inspiring Black Scientists in America

December 29, 2020 Congratulations to Aaron L. Moye from the Kim Lab who was named a Rising Star on the list of 1000 inspiring Black scientists in America! Aaron L. Moye, PhD Postdoctoral Research Fellow, Stem Cell/ Genetics, Damon Runyon Cancer Research Foundation, Burroughs Wellcome Fund, and Boston Children’s Hospital/ Harvard Medical School   Here […]... Read More »

Missed signals? A new way we vary from each other biologically

November 23, 2020 “Common variants in signaling transcription-factor-binding sites drive phenotypic variability in red blood cell traits” article released in Nature from the Zon lab! Read the Nature article here Check out Boston Children’s Hospital Discoveries article about the paper: Missed signals? A new way we vary from each other biologically... Read More »

Dr. Carla Kim Receives American Lung Association COVID-19 Research Award

November 16, 2020 Amid Pandemic, Boston Children’s Hospital’s Stem Cell Program Researcher Receives American Lung Association Research Award To Investigate Using “Organoid” Model of Lung Cancer to Test Treatment. Carla Kim, PhD received one of Lung Association’s 98 research investments to advance the understanding of Using “Organoid” Model of Lung Cancer to Test Treatment. BOSTON […]... Read More »

Stem Cell Day, November 13th, 2020

October 30, 2020 We are pleased to announce that the next Stem Cell Day will be held virtually on Friday, November 13, 2020 from 2-4pm. Please click the link below to join the event on November 13th: Passcode: 588581 Stem Cell Day Poster Stem Cell Day Agenda  ... Read More »

15th Anniversary Symposium of the Stem Cell Program

October 21, 2020 As part of Boston Children’s Hospital’s 150th and the Stem Cell Program’s 15th Anniversary, we held a day full of exciting presentations from premier stem cell scientists featuring Nobel Laureate Shinya Yamanaka. In celebration of the Stem Cell Program, here is a look back at our 15th Anniversary Symposium that took place […]... Read More »

Stem Cell Day: Call for Abstracts

September 24, 2020 Call for Poster Abstracts: We are pleased to announce that the next Stem Cell Day will be held virtually on Friday, November 13, 2020 from 2-4pm. Postdoctoral research fellows and graduate students who can present on November 13th from 2-4pm are invited to submit abstracts of their work to be included as part of the annual […]... Read More »

Lung ‘organoids’ capture early-stage lung cancer; could help test treatments

September 8, 2020 Lung ‘organoids’ capture early-stage lung cancer; could help test treatments Posted on September 4, 2020 by Nancy Fliesler | Basic/Translational, Research Tags: cancer, drug development, organoids, pulmonology, stem cells, tissue engineering (Image: Adobe Stock; Illustration Sebastian Stankiewicz, Boston Children’s Hospital) Lung cancer, the leading cancer killer in the U.S., is often missed in its earlier stages. And while recent imaging advances offer earlier detection, […]... Read More »

Ryan Flynn, MD, PhD Accepts Position in the Stem Cell Program at Boston Children’s Hospital

June 18, 2020 We are pleased to announce that Ryan Flynn, MD, PhD will become the newest Principal Investigator in the Stem Cell Program and the Division of Hematology/Oncology at Boston Children’s Hospital. He will be appointed Assistant Professor in the Stem Cell and Regenerative Biology Department at Harvard University and the Pediatrics Department at […]... Read More »

YAP Regulates Hematopoietic Stem Cell Formation in Response to the Biomechanical Forces of Blood Flow

February 6, 2020 We are proud to announce another published paper by Vanessa Lundin, Wade Sugden, and Lindsay Theodore, members of the North Lab in the Stem Cell Program! Read it here on Developmental Cell... Read More »



  • Boston Globe

    The work of Dr. Leonard Zon and Dr. George Daley is discussed in an article examining the slowing of research progress as a result of the ongoing court battle for federal funding of human embryonic stem cell research. Read More.

  • CNN

    Dr. Leonard I. Zon reflects on the latest developments in the court battle regarding federal funding of human embryonic stem cells. Read More.

  • Boston Globe

    A December 1, 2010 article in the Boston Globe‘s business section highlights the work of Verastem Inc., a local company for which Children’s Hospital Boston’s Dr. George Daley is on the scientific advisory board. “The founding scientists and advisors of Verastem are some of my favorite colleagues,” said Dr. Daley. “I am looking forward to the quest to find drugs that kill the rare cells that sustain some cancers.” Read More.

  • On NPR

    Leonard Zon, MD reflects on a decade of stem cell research. Read More.

  • Forbes

    Dr. George Daley comments on the possibility of converting specialized cells directly to other specialized cells. While other researchers are reporting very early successes, clinical trials are a long way off. “There’s a lot of experiments failing,” Daley told Forbes. “A lot of people are just taking a trial-and-error approach, and that’s fundamentally inefficient. And yet, it may create a breakthrough.” Read More.